BioCentury
ARTICLE | Clinical News

(S)-doxazosin: Began Phase I testing

March 20, 2000 8:00 AM UTC

Sepracor Inc. (SEPR), Marlborough, Mass. Product: (S)-doxazosin Business: Urological Therapeutic category: Receptor antagonist Target: Alpha adrenergic receptors Description: Single isomer form of P...